| Name | Title | Contact Details |
|---|
Hudson Health Plan is a Tarrytown, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Goode Consulting Intl is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Executive Health Exams International is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BabelBark is the most comprehensive pet health management tool available, managing pets care, records and fitness all in one place. The BabelBark mobile app for pet parents links with the software platforms for pet businesses, shelters and veterinarians to help pets live the happiest, healthiest lives possible—by connecting everyone who cares for them! Whether you love, treat, groom, train, walk or sit for pets—BabelBark helps you do it even better.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.